GGrantIndex
Sort

51,593 grants matching hepatitis

Cornell Clinical Trials Unit

$1,462,527
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2012 · AI

Nuclear receptors: action, functions, and roles in disease

$1,461,795
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Immunotherapy of low grade lymphoid malignancies

$1,461,574
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

DEMYELINATING DISEASE: VIRAL AND IMMUNE FUNCTION

$1,461,289
University Of Southern California · P01 · FY2003 · NS

Epidemiologic Study of Hepatocellular Carcinoma in the US

$1,460,631
Herbert Yu · University Of Hawaii At Manoa · R01 · FY2015 · CA

North American AIDS Cohorts Collaboration on Research and Design

$1,460,402
Richard Douglas Moore · Johns Hopkins University · U01 · FY2007 · AI

1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$1,459,550
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · HL

Liver Cancer Control Interventions for Asian Americans

$1,458,650
Moon S Chen · University Of California At Davis · P01 · FY2010 · CA

Nox family NADPH oxidases: roles in innate immunity and inflammatory disease

$1,458,602
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Regulation of Liver by Nuclear Ca2+ Signaling

$1,457,548
Michael H Nathanson · Yale University · P01 · FY2015 · DK

Regulation of Liver by Nuclear Ca2+ Signaling

$1,457,548
Michael H Nathanson · Yale University · P01 · FY2014 · DK

Saturated Fat and Protein Effects on Atherogenic Dyslipidemia

$1,457,421
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2011 · HL

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.

$1,457,206
Eliane Rohner · Universitat Bern · U01 · FY2025 · AI

Investigations of Methylmalonic Acidemia and Related Disorders

$1,457,043
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2013 · HG

Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate

$1,456,501
Steven E Shoelson · Joslin Diabetes Center · U01 · FY2007 · DK

Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate

$1,456,500
Steven E Shoelson · Joslin Diabetes Center · U01 · FY2009 · DK

Molecular Genetics Of Heritable Human Disorders

$1,456,146
Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

National Neurological AIDS Bank

$1,455,407
Elyse J Singer · University Of California Los Angeles · U01 · FY2010 · MH

A comparative evaluation of overdose prevention programs in New York City and Rhode Island

$1,455,331
Magdalena Cerda · New York University School Of Medicine · R01 · FY2024 · DA

Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

$1,455,240
Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua

$1,454,829
Mary E McCaul · Johns Hopkins University · P01 · FY2021 · AA

Structural Biology Of Virus Assembly

$1,454,743
Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

The Southeastern Cooperative Hepatitis C Research Group

$1,454,533
Stanley M Lemon · University Of Texas Med Br Galveston · U19 · FY2009 · AI

Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence

$1,453,819
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Modulation of the post-burn catabolic response by modification of androgen and glucocorticoid pathways

$1,453,394
David N Herndon · University Of Texas Med Br Galveston · P50 · FY2017 · GM